Potter van Loon, B J <br/><br/>
Fluoxetine increases insulin action in obese nondiabetic and in obese non-insulin-dependent diabetic individuals.  [electronic resource] 

 -  International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity  Feb 1992 
 - 79-85 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>Subjects--Topical Terms: </label><br/>C-Peptide--blood<br/>Diabetes Mellitus, Type 2--complications<br/>Double-Blind Method<br/>Female<br/>Fluoxetine--pharmacology<br/>Glucose--biosynthesis<br/>Humans<br/>Insulin--metabolism<br/>Insulin Secretion<br/>Liver--drug effects<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Obesity--complications